HomeCompaniesProfile

Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company… 


Company Size

11 - 50 employees

Year Founded

2019


About Gilgamesh Pharmaceuticals

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

Founders & Key People

JONATHAN SPORN

JONATHAN SPORN

Founder, Gilgamesh Pharmaceuticals

Andrew Kruegel

Andrew Kruegel

Founder, Gilgamesh Pharmaceuticals

Dalibor Sames

Dalibor Sames

Founder, Gilgamesh Pharmaceuticals

Share This Profile

More Companies

Dendron

Nimbus reduces Datadog costs by more than 60% without Manual Effort

Talus Bio

Discovering drugs that target the DNA regulome

NALA

Building Payments for the Next Billion.

Novig

America's #1 Sports Prediction Market

Bite Ninja

Remote labor for restaurants

Spero Foods

dairy reinvented from plants

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2026 BEAMSTART. All Rights Reserved.